Results demonstrate that TNF-α, seen elevated in severe COVID-19 cases, have beensignificantly reduced (P = 0.021; P < 0.001) over a 3–4-month MD interventionfor overweight/obese adults (Luisi et al., 2019; Stendell-Hollis et al.,2013). Here, TNF is linked to COVID-19.